Thursday, September 10, 2020
HHS COVID-19 Update, 9/10/2020
The heads of every center within the FDA jointly wrote an op-ed to reiterate that the agency is guided by an unbiased evaluation of scientific evidence. In the second, the FDA Commissioner highlights the importance of finding ways to incentivize manufacturers to produce pharmaceutical products and supplies domestically. See below for more details:
Senior FDA Career Executives – We're Following the Science to Protect Public Health in Pandemic: Senior FDA career executives released an op-ed in USAToday on following the science to protect public health in pandemic. They are committed to making decisions guided by the best evidence and their approach has been and will remain the gold standard that all can rely on.
The Coronavirus Pandemic Underscores the Need to Bring Drug Manufacturing Back to U.S.: FDA Commissioner Dr. Stephen Hahn and Deputy Commissioner Dr. Anand Shah released an op-ed in CNBC on the need to onshore America’s critical medical supply chain and modernize infrastructure for life sciences manufacturing.